Article thumbnail

Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort

By Jane E. Salmon, Cara Heuser, Michael Triebwasser, M. Kathryn Liszewski, David Kavanagh, Lubka Roumenina, D. Ware Branch, Tim Goodship, Veronique Fremeaux-Bacchi and John P. Atkinson

Abstract

Jane Salmon and colleagues studied 250 pregnant patients with SLE and/or antiphospholipid antibodies and found an association of risk variants in complement regulatory proteins in patients who developed preeclampsia, as well as in preeclampsia patients lacking autoimmune disease

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3062534
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia.
  2. (2008). Advances in understanding of pathogenesis of aHUS
  3. (1997). Analysis of donor splice sites in different eukaryotic organisms.
  4. (2007). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.
  5. (2009). Atypical hemolytic-uremic syndrome.
  6. (2008). Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
  7. (2008). Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.
  8. (2006). Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
  9. (2004). Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome.
  10. (2008). Complement regulatory genes and hemolytic uremic syndromes.
  11. (1999). Crystal structure of two CD46 domains reveals an extended measles virus-binding surface.
  12. (2007). Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
  13. (2000). Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP;
  14. (2007). Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.
  15. (2008). Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome.
  16. (2009). Finding the missing heritability of complex diseases.
  17. (2006). Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
  18. (2006). Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
  19. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
  20. (2008). Lojacono A
  21. (2008). Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.
  22. (2008). Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data.
  23. (2007). Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.
  24. (2010). Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.
  25. (2003). Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway.
  26. (2001). Paternal and maternal components of the predisposition to preeclampsia.
  27. (2010). Pathogenesis of preeclampsia.
  28. (2008). Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
  29. (2008). Preeclampsia and angiogenic imbalance.
  30. (2007). Preeclampsia—a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop.
  31. (2010). Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.
  32. (2010). Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney Int
  33. (2006). The complement system in the pathophysiology of pregnancy.